Tag Archives: colorectal cancer research

Research and Advocacy

Those who go into medical research often have science on the mind. Not politics. But researchers who joined us for the 2013 Call-on Congress showed how the two fields merge. Particularly when funding is involved. Fighting Colorectal Cancer at the Research and Policy Levels I love how Nancy Roach, Founder and Chair of the Board, explains the importance of advocacy AND research in the One Million Strong PSA, “I founded Fight Colorectal Cancer in 2006 because people who have been touched by colorectal cancer need a voice at the tables where decisions are being made that impact their survival.” – Nancy Roach Fighting colorectal cancer demands more than raising awareness

GRATITUDE FOR YOUR GENEROSITY: Our First Two-Year Research Grant

by Mary Miller Fight Colorectal Cancer is thrilled to announce during this holiday season that thanks to the generous donations made to the Lisa Fund, it will be awarding its first-ever two-year $100,000 grant to a scientist whose work fights advanced stage colorectal cancer. Andrea Bertotti, MD, PhD, of the Institute for Cancer Research and Treatment (IRCC) in Candiolo, Italy, has learned that his lab will receive this major grant. “His work will be ground-breaking and exactly in line with the reason Lisa Dubow created this fund—to support a promising researcher working to advance the treatment of metastatic colorectal cancer,” said Carlea Bauman, president of Fight Colorectal Cancer. Fully 100

“Report from 2012 GI Cancers Symposium” Available for Viewing

Fight Colorectal Cancer has posted a recording of its February webinar, Report from the 2012 GI Cancers Symposium, held in partnership with the Colon Cancer Alliance. Each year, the best and brightest minds in gastrointestinal oncology meet to discuss the latest research into colorectal, pancreatic, esophageal and other GI cancers. The 2012 symposium offered major news for people living with colorectal cancer, and we were proud to be able to bring that information to you. Listen in as Dr. Dan Sargent of the Mayo Clinic Cancer Center and Kim Ryan, Fight Colorectal Cancer’s Director of Patient Information Services, discuss what is on the horizon for patients living with colorectal cancer.

Highlights from ASCO 2011

While there weren’t new blockbuster announcements for colorectal cancer this year at the American Society for Clinical Oncology’s (ASCO) Annual Meeting, there was plenty of focus on making what we already have work better and on choosing the patients who will benefit the most from treatments, as well as those who might not be helped at all. (Note, many of these issues will be discussed in detail on our upcoming patient webinar.) Highlights: While adding oxaliplatin to 5-FU improves five year survival slightly for stage II colon cancer, it increases side effects, particularly tingling and numbness in the feet.  An analysis of several NSABP trials found that two or three

Leading GI Cancer Researcher Updates Patients

Last night, Dr. Edith Mitchell of Thomas Jefferson University Kimmel Cancer Center in Philadelphia, PA, updated colorectal cancer patients on the latest research and treatment news in an online webinar. Dr. Mitchell highlighted the most important news for colon and rectal cancer patients to come from the 2011 Gastrointestinal Cancers Symposium held in San Francisco last month. She answer such questions as… “Can doctors determine the chances that my cancer may return?” “Can my doctors determine if I need chemotherapy?” “Does Avastin or Erbitux benefit my stage III cancer treatment?” “Are there any promising new treatments on the horizon?”

President Obama’s State of the Union Address

This evening, the President gave his annual address to Congress and called for a freeze in domestic spending while at the same time calling for innovation and acknowledging the importance of biomedical research. “As someone who is committed to winning the fight against cancer, I was pleased to hear the President talk about the importance of innovation. However, it is counterproductive to proclaim that ‘this is our generation’s Sputnik moment’ while calling for a spending freeze for domestic programs. Now is not the time for across the board cuts to domestic spending. If we are going to find a cure for cancer in our lifetimes, we need a sustained investment

Chou Awarded 2009 Lisa Fund Grant

Jeffrey Chou, M.D.,Ph.D., is the recipient of the 2009 AACR-Colorectal Cancer Coalition Fellows Grant in memory of Lisa Dubow. Dr. Chou, a researcher at the Fred Hutchinson Cancer Center at the University of Washington in Seattle, will study how to make colorectal cancer stem cells more vulnerable to the body’s immune system. The award will be made at the AACR’s 100th Annual Meeting in Denver.  Funds for the grant were raised by C3 through the Lisa Fund. Donations to the fund are targeted for research to develop treatments for patients with late-stage colorectal cancer.

Top